Category Archive for ‘Uncategorized’

March 5, 2009

Start Half Positions In Exxon Mobil

by Rick Rouse / No Comments / Posted in Uncategorized, Daily Update, Option Trades

The Dow is taking another blow as the index is down 191 points to 6,684. The S&P is off 23 to 689 and well below the 700 level the bulls were clinging to. Things look bad but we have been expecting this bottoming process. I told you the Dow wasRead more

March 4, 2009

Freeport-McMoran Stages Furious Comeback

by Rick Rouse / No Comments / Posted in Uncategorized, Daily Update, Option Trades

We were whipsawed out of the Freeport-McMoran (FCX, $32.31, up $3.90) trade from last Friday when the stock dropped $4 yesterday. Naturally, I didn’t expect a 10% drop in the stock price when we bought the March 35 calls (FCXCG, $1.50, up $0.97) for under a $1. The calls tradedRead more

February 27, 2009

Amgen Aching

by Rick Rouse / No Comments / Posted in Uncategorized, Daily Update, Option Trades

Amgen (AMGN, $50.08, down $1.15) is no stranger to the blog and we recently closed a trade on some call options back on 2/11. I had profiled the March 60 calls (YAACL, $0.07, down $0.09) back on 2/2 and at the time they were going for $1.20. Amgen went onRead more

February 26, 2009

Trade Updates: AZO, BAC, IBM, SWY

by Rick Rouse / No Comments / Posted in Strategies, Option Trades, Uncategorized, Daily Update, Stock Earnings

Not much has been happening with AutoZone (AZO, $141.08, down $2.80) since I profiled the stock on Tuesday. The March 160 calls (AZOCL, $1.50, down $1.50) were at $2.30 and the March 130 puts (AZOOF, $3.80, down $0.80) were at $3.90. My initial hopes were that the stock would haveRead more

February 19, 2009

Dow Falls Below 7500

by Rick Rouse / No Comments / Posted in Uncategorized, Daily Update

Research in Motion (RIMM, $41.87, down $0.23) is trading lower again this morning and has hit a low of $40.97. I had mentioned yesterday that the stock looks headed below $40 but sometimes its nerve racking when you have a short position in a well-known and popular stock that isRead more

February 18, 2009

Night Owls Calling

by Rick Rouse / No Comments / Posted in Uncategorized, Daily Update, Market Analysis

Just checking in on the futures…I must be sleepwalking. At 1AM right coast time, the Dow futures are up 54, the S&P 500 is up 6.30 while the Nasdaq futures are up 5.50. This is indicating a slightly higher open to start Wednesday’s trading session but European markets have yetRead more

February 11, 2009

Dow Plunges on Uncertainty

by Rick Rouse / No Comments / Posted in Uncategorized, Daily Update, Market Analysis

The market hates uncertainty and Tuesday all Wall Street could do was watch with despair as stocks were sent plunging. The market sat on the fence on Monday and traded flat and that was pretty much the deal until Treasury Secretary Timothy Geithner spoke. The more he spoke however, theRead more

February 1, 2009

Weekly Wrap for 2/1/09

by Rick Rouse / No Comments / Posted in Momentum Stocks Weekly, Option Trades, Uncategorized, Market Analysis

1. Commentary 2. Month-end Review 3. Opening and Managing a Trading Account 4. Using Option Straddles 5. Current Trades 6. Earnings 7. Closing Thoughts ************************************************** 1. Commentary The market suffered its fourth straight losing week but the losses were kept to less than 1%. The Dow got off to aRead more

January 21, 2009

Gold Back on Radar

by Rick Rouse / No Comments / Posted in Gold, Uncategorized, Daily Update

In mid-December we rode gold for a three-day trade that netted quite a few double-digit returns. The “Big Three” is what I like to call my Watch List for gold although there are five or six on the list that I follow. Here is an excerpt from the December 15Read more

January 12, 2009

Before the Bell – Action in Genentech

by Rick Rouse / No Comments / Posted in Daily Update, Company Commentary, Mergers and Acquisitions, Option Trades, Uncategorized

Genentech (DNA, $86.34, up $1.94) will be in the headlines a lot this week and there may be an opportunity for a couple of trades. News surfaced late Friday that Switzerland based Roche is preparing a fresh offer for Genentech which it already owns a 56% stake in. The stockRead more

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.